These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17593009)

  • 1. Retinal and systemic pharmacokinetics of the anti-inflammatory drug cloricromene following oral administration in the rat and rabbit.
    Bucolo C; Maugeri F; Maltese A; Ward KW
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):257-63. PubMed ID: 17593009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene.
    Bucolo C; Maltese A; Maugeri F; Busà B; Puglisi G; Pignatello R
    J Pharm Pharmacol; 2004 Jul; 56(7):841-6. PubMed ID: 15233861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of availability of cloricromene at brain level by a lipophilic prodrug.
    Pignatello R; Maltese A; Maugeri F; Bucolo C
    J Pharm Pharmacol; 2006 Jul; 58(7):1001-5. PubMed ID: 16805962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of a coumarin derivative in diabetic rats.
    Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.
    Lidbury PS; Cirillo R; Vane JR
    Br J Pharmacol; 1993 Sep; 110(1):275-80. PubMed ID: 8220889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the coumarin derivative cloricromene acid in rabbit plasma and platelets.
    Mariot R; Zangirolami L; Bellato P; Chen S; Pieraccini G; Moneti G
    J Chromatogr; 1992 Apr; 576(1):143-8. PubMed ID: 1500448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat.
    Fries W; Mazzon E; Sturiale S; Giofré MR; Lo Presti MA; Cuzzocrea S; Campo GM; Caputi AP; Longo G; Sturniolo GC
    Life Sci; 2004 Apr; 74(22):2749-56. PubMed ID: 15043989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies.
    Saitta A; Bonaiuto M; Giordano G; Saitta MN; Castaldo M; Cinquegrani M; Squadrito G; Canale P; Altavilla D; Campo GM; Caputi AP; Squadrito F
    Pharmacology; 1996 Jan; 52(1):8-15. PubMed ID: 8966205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloricromene, a semi-synthetic coumarin derivative, inhibits tumor necrosis factor-alpha production at a pre-transcriptional level.
    Corsini E; Lucchi L; Binaglia M; Viviani B; Bevilacqua C; Monastra G; Marinovich M; Galli CL
    Eur J Pharmacol; 2001 Apr; 418(3):231-7. PubMed ID: 11343695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of cloricromene and its active metabolite in rabbit aqueous humor by high-performance liquid chromatography.
    Maltese A; Bucolo C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(1):153-8. PubMed ID: 11863286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloricromene effect on the enzyme activities of the tryptophan-nicotinic acid pathway in diabetic/hyperlipidemic rabbits.
    Ragazzi E; Costa CV; Comai S; Bertazzo A; Caparrotta L; Allegri G
    Life Sci; 2006 Jan; 78(8):785-94. PubMed ID: 16126232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of myocardial damage by cloricromene during ischemia-reperfusion in the rabbit.
    Milei J; Llesuy S; Ferreira R; Grana D; Prosdocimi M; Boveris A
    Cardioscience; 1992 Jun; 3(2):97-105. PubMed ID: 1643242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
    Lee JH; Shin JH; Lee MG
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single and multiple-dose pharmacokinetics of tepoxalin and its active metabolite after oral administration to rabbits (Oryctolagus cuniculus).
    Pollock CG; Carpenter JW; Koch DE; Hunter RP
    J Vet Pharmacol Ther; 2008 Apr; 31(2):171-4. PubMed ID: 18307510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues.
    Matsumoto H; Nakamura Y; Iida H; Ito K; Ohguro H
    Exp Eye Res; 2006 Aug; 83(2):348-56. PubMed ID: 16635490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
    Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8.
    Chung SY; Han KS; Chung YK; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):187-200. PubMed ID: 9667073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.